
About Micals Pharma Private Limited
Data last updated:
Micals Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 March 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1998PTC114070. Its GSTIN is 27AABCM4682L1Z2 (Maharashtra).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Veena Upen Bhayani and Upendra Chandulal Bhayani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 307 Parshwanath Apartment3Rd Floor Nahur Road Parshwanath Nagar Mulund (W), Mumbai, Maharashtra, India – 400080.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.4 Cr, a growth of 101% compared to the previous year. For the same year it recorded a net profit of ₹4.24 Lakh (net margin 1.8%) and EBITDA of ₹4.62 Lakh (EBITDA margin 1.9%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹54.99 Lakh on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website micalspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address307 Parshwanath Apartment3Rd Floor Nahur Road Parshwanath Nagar Mulund (W), Mumbai, Maharashtra, India – 400080
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Micals Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Micals Pharma Private Limited
FY 2025 filings availableMicals Pharma Private Limited reported revenue of ₹2.4 Cr (up 101% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 101% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 237% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹4.62 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹4.24 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.9% | |
| Net Profit Margin | 1.8% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Micals Pharma are in the company report.
: available in the company report
Board of Directors of Micals Pharma Private Limited
Micals Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veena Upen Bhayani | Director | 20 Mar 1998 | 28 Years 7 Months | Current |
| Upendra Chandulal Bhayani | Director | 20 Mar 1998 | 28 Years 7 Months | Current |
Peer Comparison
Micals Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Intact Bio Laboratories Private Limited | ₹2.41 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Kanpur, Uttar Pradesh, India |
| Chemonix India Pvt. Ltd. | ₹2.4 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Ahmedabad, Gujarat, India |
| Micals Pharma Private Limited this company | ₹2.4 Cr (FY 2025) | •••• | •••• | 101.0% | •••• | Mumbai, Maharashtra, India |
| Colosiem Healthcare Private Limited | ₹2.4 Cr (FY 2025) | •••• | •••• | 40.0% | •••• | Hyderabad, Telangana, India |
Peers are the companies nearest to Micals Pharma by revenue, above and below it, in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Micals Pharma Private Limited is audited by NILESH SALOT & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NILESH SALOT & ASSOCIATES | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jun 2021 | Others | ₹4.99 Lakh | Open |
| 23 Aug 1999 | Bank of India | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Legal Cases
Micals Pharma Private Limited has 6 court cases on record: 5 filed by Micals Pharma, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI REV APP) | Filed against the company by Ms Mayo Remedies Ltd. 3 | Disposed |
| Bombay High Court | Court case (CHS) | Filed by the company against Mayo Remedies Ltd. and Micals Pharma Pvt. Ltd. | Disposed |
| Bombay High Court | Appeal | Filed by the company against The Official Liquidator, High Court, Bombay | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against Mayo Remedias Ltd | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against Mayo Remedias Ltd. | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Micals Pharma.
: available in the company report
Recent Activity
Micals Pharma Private Limited has 4 board changes on record since 1998: 2 appointments and 2 cessations. The latest: Chandulal Raghavji Bhayani ceased to be Director on 20 Sep 2012.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Micals Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCM4682L1Z2 | Maharashtra | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Micals Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 March 1998 (28+ years old) and is registered under CIN U24239MH1998PTC114070.
Micals Pharma has 2 current directors:
- Veena Upen Bhayani - Director
- Upendra Chandulal Bhayani - Director
The latest financial statements of Micals Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Micals Pharma is 27AABCM4682L1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Micals Pharma is U24239MH1998PTC114070. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Micals Pharma has 6 court cases on record: 5 filed by the company and 1 filed against it. Most are in the high courts.
Micals Pharma was incorporated on 20 March 1998, making it 28+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Micals Pharma by revenue are Intact Bio Laboratories Private Limited, Chemonix India Pvt. Ltd, Colosiem Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Chandulal Raghavji Bhayani ceased to be Director on 20 Sep 2012. Nayna Virendra Bhayani ceased to be Director on 20 Sep 2012. Upendra Chandulal Bhayani was appointed as Director on 20 Mar 1998. Micals Pharma has 4 board changes on record in total.
Micals Pharma can be reached through the website micalspharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Micals Pharma is at 307 Parshwanath Apartment3Rd Floor Nahur Road Parshwanath Nagar Mulund W, Mumbai, Maharashtra, India – 400080.